Abel Hall LLC’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Sell
490
-55
-10% -$22.5K 0.04% 674
2026
Q2
$213K Buy
545
+37
+7% +$15.6K 0.04% 705
2026
Q1
$240K Buy
508
+69
+16% +$34.7K 0.05% 518
2025
Q4
$205K Buy
+439
New +$204K 0.05% 531

Other funds holding HCA

Abel Hall LLC's HCA Position: Q3 2026 in Review

Abel Hall LLC reduced its HCA Healthcare (HCA) stake by 10% in Q3 2026, selling an estimated $22.5K and leaving 490 shares worth $209K. The position accounts for 0.04% of the portfolio, ranked #674.

Abel Hall LLC first reported a position in HCA in Q4 2025 and has held it in 4 quarters since. The position peaked at $240K in Q1 2026. 489 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Abel Hall LLC held 490 shares of HCA Healthcare worth $209K as of Q3 2026.
  • Abel Hall LLC sold 55 HCA Healthcare shares in Q3 2026, an estimated $22.5K.
  • HCA Healthcare made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #674 holding.
  • Abel Hall LLC first reported a position in HCA Healthcare in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's HCA Healthcare position peaked at $240K in Q1 2026.
  • 489 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.